KemPharm Inc

NASDAQ:KMPH   3:59:53 PM EDT
8.22
+0.19 (+2.37%)
Earnings Announcements

KemPharm Reports Q3 2021 Financial Results

Published: 11/10/2021 22:29 GMT
KemPharm Inc (KMPH) - Kempharm Reports Third Quarter 2021 Financial Results and Corporate Updates.
Q3 Loss per Share $0.05.
Q3 Revenue $2.0 Million Versus $1.9 Million.
Revenue is expected to be $2.29 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $2.5 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.